Bottle Label 60 mg (71610 0743 30)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 71610-743
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71610-743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Chemical Structure (Duloxetine 01)
Figure 1 (Duloxetine 02)
The text provided is a graph showing the proportion of patients with relapse over time. It appears to compare the effectiveness of a placebo treatment with a medication called Dulovetie delayecheleass capeuls. The graph shows that the medication has a significant delay in relapse compared to the placebo. However, without further context or clearer text, it is difficult to provide more specific details or conclusions.*
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 8 (Duloxetine 08)
Figure 9 (Duloxetine 09)
Figure 10 (Duloxetine 10)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
